glutamic acid and daunorubicin

glutamic acid has been researched along with daunorubicin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Braszko, JJ; Holownia, A; Jakubow, P; Kaliszewski, J; Krawczuk-Rybak, M; Muszynska-Roslan, K; Trofimiuk, E1
Attarbaschi, A; Dworzak, MN; Haas, OA; Hochreiter, D; Hutter, C; Kasper, DC; Kornmüller, R; Mann, G; Pichler, H; Pötschger, U; Steiner, M1

Other Studies

3 other study(ies) available for glutamic acid and daunorubicin

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Cerebrospinal fluid excitatory amino acids and tau protein in children with acute lymphoblastic leukemia treated according to the BFM protocol.
    Acta haematologica, 2004, Volume: 112, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Aspartic Acid; Child; Daunorubicin; Excitatory Amino Acids; Glutamic Acid; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; tau Proteins; Vincristine

2004
Asparagine and aspartic acid concentrations in bone marrow versus peripheral blood during Berlin-Frankfurt-Münster-based induction therapy for childhood acute lymphoblastic leukemia.
    Leukemia & lymphoma, 2012, Volume: 53, Issue:9

    Topics: Adolescent; Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Asparagine; Aspartic Acid; Bone Marrow; Child; Child, Preschool; Daunorubicin; Drug Administration Schedule; Female; Glutamic Acid; Glutamine; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Time Factors; Treatment Outcome; Vincristine

2012